These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18041028)

  • 41. Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.
    Kaufman BM; Summers PL; Dubois DR; Cohen WH; Gentry MK; Timchak RL; Burke DS; Eckels KH
    Am J Trop Med Hyg; 1989 Nov; 41(5):576-80. PubMed ID: 2817214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates.
    Bernardo L; Izquierdo A; Alvarez M; Rosario D; Prado I; López C; Martínez R; Castro J; Santana E; Hermida L; Guillen G; Guzmán MG
    Antiviral Res; 2008 Nov; 80(2):194-9. PubMed ID: 18602424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The stem region of premembrane protein plays an important role in the virus surface protein rearrangement during dengue maturation.
    Zhang Q; Hunke C; Yau YH; Seow V; Lee S; Tanner LB; Guan XL; Wenk MR; Fibriansah G; Chew PL; Kukkaro P; Biukovic G; Shi PY; Shochat SG; Grüber G; Lok SM
    J Biol Chem; 2012 Nov; 287(48):40525-34. PubMed ID: 23035113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation and characterization of monoclonal antibodies against dengue virus type 1 for epitope mapping and serological detection by epitope-based peptide antigens.
    Chen YC; Huang HN; Lin CT; Chen YF; King CC; Wu HC
    Clin Vaccine Immunol; 2007 Apr; 14(4):404-11. PubMed ID: 17287314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes.
    Xu M; Hadinoto V; Appanna R; Joensson K; Toh YX; Balakrishnan T; Ong SH; Warter L; Leo YS; Wang CI; Fink K
    J Immunol; 2012 Dec; 189(12):5877-85. PubMed ID: 23152560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2.
    Lai CY; Hu HP; King CC; Wang WK
    J Biomed Sci; 2008 Jan; 15(1):15-27. PubMed ID: 17768670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Partial maturation: an immune-evasion strategy of dengue virus?
    Rodenhuis-Zybert IA; Wilschut J; Smit JM
    Trends Microbiol; 2011 May; 19(5):248-54. PubMed ID: 21388812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice.
    Valdés I; Bernardo L; Gil L; Pavón A; Lazo L; López C; Romero Y; Menendez I; Falcón V; Betancourt L; Martín J; Chinea G; Silva R; Guzmán MG; Guillén G; Hermida L
    Virology; 2009 Nov; 394(2):249-58. PubMed ID: 19783271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice.
    Men RH; Bray M; Lai CJ
    J Virol; 1991 Mar; 65(3):1400-7. PubMed ID: 1995950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amino acid and phenotypic changes in dengue 2 virus associated with escape from neutralisation by IgM antibody.
    Lok SM; Ng ML; Aaskov J
    J Med Virol; 2001 Oct; 65(2):315-23. PubMed ID: 11536239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice.
    Ocazionez Jimenez R; Lopes da Fonseca BA
    Vaccine; 2000 Nov; 19(6):648-54. PubMed ID: 11090717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice.
    Gil L; López C; Lazo L; Valdés I; Marcos E; Alonso R; Gambe A; Martín J; Romero Y; Guzmán MG; Guillén G; Hermida L
    Int Immunol; 2009 Oct; 21(10):1175-83. PubMed ID: 19692540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structure of the immature dengue virus at low pH primes proteolytic maturation.
    Yu IM; Zhang W; Holdaway HA; Li L; Kostyuchenko VA; Chipman PR; Kuhn RJ; Rossmann MG; Chen J
    Science; 2008 Mar; 319(5871):1834-7. PubMed ID: 18369148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.
    Pattnaik P; Babu JP; Verma SK; Tak V; Rao PV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):184-94. PubMed ID: 17011249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the ectodomain of the envelope protein of dengue virus type 4: expression, membrane association, secretion and particle formation in the absence of precursor membrane protein.
    Hsieh SC; Tsai WY; Nerurkar VR; Wang WK
    PLoS One; 2014; 9(6):e100641. PubMed ID: 24950216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression of tick-borne encephalitis virus prM-E protein in insect cells and studies on its antigenicity].
    Liu YL; Si BY; Hu Y; Zhang Y; Yang YH; Zhu QY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec; 19(4):335-9. PubMed ID: 16415990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion.
    Goto A; Yoshii K; Obara M; Ueki T; Mizutani T; Kariwa H; Takashima I
    Vaccine; 2005 Apr; 23(23):3043-52. PubMed ID: 15811651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonal antibody against Saint Louis encephalitis prM viral protein.
    Pupo-Antúnez M; Vázquez S; Sosa AL; Caballero Y; Vásquez Y; Morier L; Álvarez M; Guzmán MG
    J Virol Methods; 2015 Jun; 218():14-8. PubMed ID: 25744380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An optimized expression vector for improving the yield of dengue virus-like particles from transfected insect cells.
    Charoensri N; Suphatrakul A; Sriburi R; Yasanga T; Junjhon J; Keelapang P; Utaipat U; Puttikhunt C; Kasinrerk W; Malasit P; Sittisombut N
    J Virol Methods; 2014 Sep; 205():116-23. PubMed ID: 24814967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic analysis of dengue virus type 3 isolated in Buenos Aires, Argentina.
    Barrero PR; Mistchenko AS
    Virus Res; 2008 Jul; 135(1):83-8. PubMed ID: 18400327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.